Widely available lysosome targeting agents should be considered as potential therapy for COVID-19
Jan Homolak, Ivan Kodvanj
Topics & Concepts
LysosomeCoronavirus disease 2019 (COVID-19)PharmacologyEndosomeChloroquineDrug repositioningMedicineCoronavirusSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Mechanism (biology)Mechanism of actionDrugIntensive care medicineChemistryDiseaseCellInfectious disease (medical specialty)ImmunologyIn vitroMalariaEpistemologyPhilosophyEnzymeBiochemistryPathologyCalcium signaling and nucleotide metabolismCOVID-19 Clinical Research StudiesNeonatal Health and Biochemistry